section name header

Pronunciation

floo-FEN-a-zeen

Classifications

Therapeutic Classification: antipsychotics

Pharmacologic Classification: phenothiazines

Indications

BEERS REMS


Action

  • Alters the effects of dopamine in the CNS.
  • Has anticholinergic and alpha-adrenergic blocking activity.
Therapeutic effects:
  • Diminished signs and symptoms of psychoses.

Pharmacokinetics

Absorption: Well absorbed after PO/IM administration. Decanoate salt in sesame oil has delayed onset and prolonged action because of delayed release from oil vehicle and subsequent delayed release from fatty tissues.

Distribution: Widely distributed. Crosses the blood-brain barrier.

Protein Binding: 90%.

Metabolism/Excretion: Highly metabolized by the liver; undergo enterohepatic recirculation.

Half-Life: Fluphenazine hydrochloride: 33 hr; fluphenazine decanoate: 6.8–9.6 days.

Time/Action Profile

(antipsychotic activity)

ROUTEONSETPEAKDURATION
PO hydrochloride1 hrunknown6–8 hr
IM decanoate24–72 hr48–96 hr4 wk



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypertension, hypotension, tachycardia

Derm: photosensitivity, pigment changes, rash

EENT: blurred vision, dry eyes

Endo: galactorrhea

GI: anorexia, constipation, hepatitis, dry mouth, ileus, nausea

GU: urinary retention

Hemat: AGRANULOCYTOSIS, leukopenia, thrombocytopenia

Metab: weight gain

Neuro: extrapyramidal reactions, NEUROLEPTIC MALIGNANT SYNDROME, sedation, tardive dyskinesia

Misc: allergic reactions

Interactions

Drug-drug:

Route/Dosage

Fluphenazine Hydrochloride

Fluphenazine Decanoate

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Fluphenazine hydrochloride is compatible in syringe with.

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Prolixin, Prolixin Decanoate

Code

NDC Code